Research Site — Langhorne, Pennsylvania

Research Site is a clinical research site located in Langhorne, Pennsylvania, United States.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Research Site has participated in 17 clinical trials with 1 currently active.

Therapeutic areas: Acute Coronary Syndrome, Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck, Resistant Hypertension.

Sponsors: AstraZeneca, Amgen, DalCor Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 17 clinical trials on record, with 1 currently active. Their work covers Acute Coronary Syndrome, Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck, Resistant Hypertension.

Is Research Site accredited by Crixeo Health?

Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.